Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Patients already on a stable GLP-1 protocol who want metabolic support during their fat-loss phase tend to do well adding MOTS-C two or three times per week
That might enhance insulin sensitivity when added to lifestyle interventions
Key warnings include risk of thyroid C-cell tumors, pancreatitis, gallbladder disease, risk of acute kidney injury with severe gastrointestinal adverse reactions, and potential diabetic retinopathy complications
You should consider an evaluation if: You are interested in GLP-1 treatment but are not sure whether you are an appropriate candidate
In its Q3 2024 letter to shareholders, Hims indicated it intends to offer branded medications once the company is able to gain consistent supply of these medications. But this pivot would come with challenges
